References
- Polack FP, Thomas SJ, Kitchin N, et al. C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020 Dec 31;383(27):2603–2615. Epub 2020 Dec 10. PMID: 33301246; PMCID: PMC7745181.
- Nakayama T. Causal relationship between immunological responses and adverse reactions following vaccination. Vaccine. 2019 Jan 7;37(2):366–371. Epub 2018 Nov 30. PMID: 30503656.
- Yelehe-Okouma, Yelehe-Okouma M, Czmil-Garon J, et al. Drug-induced aseptic meningitis: a mini-review. Fundam Clin Pharmacol. 2018 Jun;32(3):252–260.
- Xia X. Domains and functions of spike protein in SARS-Cov-2 in the context of vaccine design. Viruses. 2021;13(1):109.
- Nuovo G, Magro C, Shaffer T, et al. Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein. Ann Diagn Pathol. 2021;51:151682.
- Saito K, Shimizu T, Suzuki-Inoue K, et al. Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine. Neurol Sci. 2021;42(11):4433–4435.
- Meo SA, Bukhari IA, Akram J, et al. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and moderna vaccines. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663–1669.
- Tano E, San Martin S, Girgis S, et al. Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine. J Pediatric Infect Dis Soc. 2021 10 10 Jul;962–966.
- Yıldırım R, Cansu DÜ, Arık D, et al. Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review. Rheumatol Int. 2021 Mar 9;41(10):1845–1853.